Volume 20, Issue 4, Pages e7 (April 2017)

Slides:



Advertisements
Similar presentations
Functional Elements in the Human Genome
Advertisements

Comprehensively Evaluating cis-Regulatory Variation in the Human Prostate Transcriptome by Using Gene-Level Allele-Specific Expression  Nicholas B. Larson,
Volume 16, Issue 5, Pages (August 2016)
Volume 20, Issue 2, Pages e8 (February 2017)
Volume 21, Issue 1, Pages e6 (July 2017)
Volume 20, Issue 13, Pages (September 2017)
The 3D Genome Shapes Up For Pluripotency
Genetic-Variation-Driven Gene-Expression Changes Highlight Genes with Important Functions for Kidney Disease  Yi-An Ko, Huiguang Yi, Chengxiang Qiu, Shizheng.
Volume 16, Issue 5, Pages (May 2015)
High-Resolution Profiling of Histone Methylations in the Human Genome
Volume 18, Issue 9, Pages (February 2017)
Discovery and Characterization of piRNAs in the Human Fetal Ovary
Volume 23, Issue 7, Pages (May 2018)
Volume 8, Issue 4, Pages (April 2017)
Volume 54, Issue 1, Pages (April 2014)
Volume 10, Issue 5, Pages (May 2018)
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Hotspots of De Novo Point Mutations in Induced Pluripotent Stem Cells
Volume 9, Issue 3, Pages (September 2017)
Lucas J.T. Kaaij, Robin H. van der Weide, René F. Ketting, Elzo de Wit 
Volume 9, Issue 5, Pages (November 2017)
Volume 32, Issue 1, Pages e4 (July 2017)
Volume 23, Issue 4, Pages (April 2018)
Identification and Validation of Genetic Variants that Influence Transcription Factor and Cell Signaling Protein Levels  Ronald J. Hause, Amy L. Stark,
Volume 44, Issue 1, Pages (October 2011)
Transcriptional Consequences of 16p11
A Massively Parallel Reporter Assay of 3′ UTR Sequences Identifies In Vivo Rules for mRNA Degradation  Michal Rabani, Lindsey Pieper, Guo-Liang Chew,
Adrien Le Thomas, Georgi K. Marinov, Alexei A. Aravin  Cell Reports 
PheWAS and Beyond: The Landscape of Associations with Medical Diagnoses and Clinical Measures across 38,662 Individuals from Geisinger  Anurag Verma,
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 7, Issue 1, Pages (April 2014)
Volume 20, Issue 4, Pages e6 (April 2017)
Volume 20, Issue 6, Pages (August 2017)
Volume 22, Issue 4, Pages (January 2018)
Dynamic Gene Regulatory Networks of Human Myeloid Differentiation
Volume 24, Issue 4, Pages (July 2018)
Transcriptional Profiling of Quiescent Muscle Stem Cells In Vivo
Integrative Multi-omic Analysis of Human Platelet eQTLs Reveals Alternative Start Site in Mitofusin 2  Lukas M. Simon, Edward S. Chen, Leonard C. Edelstein,
Biased Allelic Expression in Human Primary Fibroblast Single Cells
Volume 20, Issue 4, Pages e6 (April 2017)
High-Resolution Profiling of Histone Methylations in the Human Genome
Xin Li, Alexis Battle, Konrad J. Karczewski, Zach Zappala, David A
Volume 16, Issue 8, Pages (August 2016)
Volume 17, Issue 6, Pages (November 2016)
Michal Levin, Tamar Hashimshony, Florian Wagner, Itai Yanai 
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 20, Issue 4, Pages e7 (April 2017)
Human Promoters Are Intrinsically Directional
Volume 8, Issue 4, Pages (April 2017)
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Volume 25, Issue 13, Pages e5 (December 2018)
Volume 14, Issue 6, Pages (June 2014)
Volume 22, Issue 3, Pages (January 2018)
Volume 10, Issue 10, Pages (October 2017)
Volume 21, Issue 6, Pages e6 (December 2017)
Volume 132, Issue 6, Pages (March 2008)
Volume 11, Issue 11, Pages (June 2015)
Volume 122, Issue 6, Pages (September 2005)
Volume 14, Issue 6, Pages (June 2014)
Volume 6, Issue 5, Pages (May 2010)
Volume 7, Issue 2, Pages (August 2010)
Volume 16, Issue 2, Pages (February 2015)
Volume 1, Issue 1, Pages (July 2015)
Volume 10, Issue 3, Pages (March 2017)
CaQTL analysis identifies genetic variants affecting human islet cis-RE use. caQTL analysis identifies genetic variants affecting human islet cis-RE use.
Lab-Specific Gene Expression Signatures in Pluripotent Stem Cells
Genetic and Epigenetic Regulation of Human lincRNA Gene Expression
Volume 12, Issue 6, Pages (June 2019)
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor α-Bound Enhancers  Julia B. Carleton, Kristofer.
The 3D Genome in Transcriptional Regulation and Pluripotency
Presentation transcript:

Volume 20, Issue 4, Pages 533-546.e7 (April 2017) Large-Scale Profiling Reveals the Influence of Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells  Christopher DeBoever, He Li, David Jakubosky, Paola Benaglio, Joaquin Reyna, Katrina M. Olson, Hui Huang, William Biggs, Efren Sandoval, Matteo D’Antonio, Kristen Jepsen, Hiroko Matsui, Angelo Arias, Bing Ren, Naoki Nariai, Erin N. Smith, Agnieszka D’Antonio- Chronowska, Emma K. Farley, Kelly A. Frazer  Cell Stem Cell  Volume 20, Issue 4, Pages 533-546.e7 (April 2017) DOI: 10.1016/j.stem.2017.03.009 Copyright © 2017 Terms and Conditions

Cell Stem Cell 2017 20, 533-546.e7DOI: (10.1016/j.stem.2017.03.009) Copyright © 2017 Terms and Conditions

Figure 1 Summary of eQTL Results and Power Analysis (A) Number of genes with (blue) and without (turquoise) significant eQTLs by Gencode gene type (see Table S1 for all gene types). (B–E) log10 RNA-seq by expectation maximization (RSEM) transcripts per million (TPM) gene expression estimates stratified by lead variant genotype for POU5F1 (B), CXCL5 (C), BCL9 (D), and FGFR1 (E). The x axis is labeled with the genotypes for the lead variant for each eQTL. We used residual expression values to identify eQTLs but plot raw TPM here to demonstrate the effect of the eQTL on the raw expression data. (F and G) Number of eGenes (F) and percent unique eGenes (G) versus number of samples for 44 GTEx v6 tissues (blue circles), 131 unrelated subjects from this study (red diamond), or all 215 subjects from this study (red star). The outlier GTEx tissue in (G) is testis. See also Figure S1 and Tables S1 and S2. Cell Stem Cell 2017 20, 533-546.e7DOI: (10.1016/j.stem.2017.03.009) Copyright © 2017 Terms and Conditions

Figure 2 eQTL Functional Annotation Enrichments (A and B) −log10 Fisher’s exact enrichment p values for 4,616 eQTL lead SNVs/indels in Roadmap Epigenomics DHSs (A) and ENCODE DHSs (B). The replicate H1 hESC DHS experiments in (B) were performed in different laboratories, which may account for their different levels of enrichment. (C) Fisher’s exact ORs for ENCODE H1 hESC TF ChIP-seq peaks. The color indicates whether the enrichment was significant, which can vary because of the number of ChIP-seq peaks for each particular mark. See also Table S3. Cell Stem Cell 2017 20, 533-546.e7DOI: (10.1016/j.stem.2017.03.009) Copyright © 2017 Terms and Conditions

Figure 3 peQTN Characteristics (A) Number of stem cell DHSs overlapped by eQTNs for four stem cell lines from Roadmap Epigenomics (H1, H9, iPS DF 6.9, and iPS DF 19.11). (B) Number of peQTNs per eGene for 1,526 eGenes with at least one peQTN. (C) peQTN for MED30 that overlaps a CEBPB ChIP-seq peak and disrupts a known CEBPB motif. The scatterplot shows the −log10 association p value from EMMAX for peQTN (purple point), other significant eQTL variants (green points), and variants not associated with MED30 expression (blue points). ENCODE H1 hESC CEBPB ChIP-seq peaks (blue rectangles) and chromHMM chromatin state predictions (multi-color track) are displayed. (D) CTCF ChIP-seq peak coverage (Z score of log10 counts) from five iPSC lines for peaks containing peQTNs predicted to disrupt CTCF binding and that had evidence of CTCF allelic bias in the ChIP-seq data. Counts are stratified by the genotype of the peQTN: 0, 1, and 2 for low, intermediate, and high predicted binding of CTCF, respectively. The peak coverage is significantly associated with the peQTN genotype (r = 0.087, p = 0.039, Pearson). (E) The P1 region with the reference allele drives expression in 96% of embryos, whereas the alternate allele leads to a complete loss of expression. (F and G) Image showing a tailbud stage Ciona embryo electroporated with Snail P1 (ref. allele) > GFP (F) or Snail P1 (alt. allele) > GFP (G). Expression can be seen in the tail muscle for the reference allele. Images were taken at the same exposure time to allow for direct comparison. See also Figure S2 and Tables S4 and S5. Cell Stem Cell 2017 20, 533-546.e7DOI: (10.1016/j.stem.2017.03.009) Copyright © 2017 Terms and Conditions

Figure 4 CNV eQTL Effect Sizes and Functional Annotation (A) Density plot of absolute effect size for eQTLs with or without CNV lead variants. (B) Effect sizes for lead CNVs for eGenes where no significant CNV overlaps the eGene. (C) Enrichment p values (Fisher’s exact test) of Roadmap stem cell DHS and histone modification ChIP-seq peaks in lead CNVs for eGenes where no significant CNV overlaps the eGene. Different points for each mark represent different Roadmap stem cell lines. (D) Gene expression estimates for seven genes associated with a single mCNV in 131 unrelated donors. (E) Genomic location of mCNV on chromosome 7 along with six of seven associated genes (indicated by boxes). The mCNV overlaps a CEBPB ChIP-seq peak, DHS, and predicted enhancer from the H1 hESC line. Cell Stem Cell 2017 20, 533-546.e7DOI: (10.1016/j.stem.2017.03.009) Copyright © 2017 Terms and Conditions

Figure 5 Effect of Rare Variants on Gene Expression (A and B) Distribution of gene expression estimates (probabilistic estimation of expression residuals [PEER] Z scores; STAR Methods) for genes with (green) or without (blue) an rpdSNV (A) and without an rpdSNV (blue), with an rpdSNV with CADD Phred greater than 20 (green), or with an rpdSNV with a phyloP score greater than three (orange) (B). (C and D) Distribution of gene expression estimates for genes without rare genic duplications (blue), with rare genic duplications (green), or with rare exonic duplications (orange) (C) and without rare genic deletions (blue), with rare genic deletions (green), or with rare exonic deletions (orange) (D). See also Figure S3. Cell Stem Cell 2017 20, 533-546.e7DOI: (10.1016/j.stem.2017.03.009) Copyright © 2017 Terms and Conditions

Figure 6 Heterogeneity of XCR following Reprogramming (A) Average expression for 120 X chromosome genes in samples with significant ASE versus samples without significant ASE. (B and C) Distribution of estimated AIFs for X chromosome (B) and autosomal genes (C) for one representative RNA-seq sample. AIF is the percentage of transcripts estimated to come from the haplotype that is more expressed. (D) From left to right, the heatmaps show passage, XIST and TSIX expression, X chromosome AIF distribution, and autosomal AIF distribution for each RNA-seq sample from female-derived iPSCs. Each row corresponds to one sample. Samples were sorted by XIST expression before plotting. (E and F) Estimated AIFs across the p (E) and q (F) arms of the X chromosome. Each point represents an estimate of the AIF for a gene/sample pair. Box 1 shows a largely reactivated cluster of genes with most AIFs near 50%, whereas box 2 shows a cluster of genes that have not been reactivated with AIFs closer to 100%. Cell Stem Cell 2017 20, 533-546.e7DOI: (10.1016/j.stem.2017.03.009) Copyright © 2017 Terms and Conditions